Esperion Therapeutics (ESPR) Stock Chart & Stock Price History $1.40 -0.02 (-1.41%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$1.40 0.00 (0.00%) As of 08/1/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Esperion Therapeutics Stock Price Performance The Esperion Therapeutics (ESPR) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 32.04%, with a year-to-date return of -36.36%. In the past month, the stock has increased 21.74%, reflecting recent market activity. As of the latest close, Esperion Therapeutics traded at $1.40 with a market cap of $277.48 million and volume of 2.63 million shares. Five years ago, the stock traded at $37.63, representing a 96.28% decrease over that period. At the time, it had a market cap of $1.05 billion and a volume of 896,564 shares. Receive ESPR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Esperion Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-11.95%1 Month Performance+21.74%3 Month Performance+28.44%Year-To-Date Performance-36.36%1 Year Performance-32.04%5 Year Performance-96.28% ESPR Stock Chart for Saturday, August, 2, 2025 ESPR Chart by TradingView Esperion Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025$1.42$1.40-1.41%$1.42$1.342.63 million shs$277.48 million07/31/2025$1.41$1.42+0.71%$1.43$1.363.29 million shs$281.44 million07/30/2025$1.47$1.41-4.08%$1.52$1.404.36 million shs$279.46 million07/29/2025$1.59$1.47-7.55%$1.63$1.444.84 million shs$291.35 million07/28/2025$1.51$1.59+5.30%$1.74$1.506.18 million shs$315.14 million07/25/2025$1.49$1.51+1.34%$1.58$1.455.16 million shs$299.28 million07/24/2025$1.33$1.49+12.03%$2.08$1.3234.84 million shs$295.32 million07/23/2025$1.22$1.33+9.02%$1.38$1.215.55 million shs$263.61 million07/22/2025$1.15$1.22+6.09%$1.24$1.133.23 million shs$241.80 million07/21/2025$1.17$1.15-1.71%$1.22$1.141.87 million shs$227.93 million Get the Latest News and Ratings for ESPR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Esperion Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025$1.24$1.17-5.65%$1.27$1.142.93 million shs$231.89 million07/17/2025$1.12$1.24+10.71%$1.27$1.113.63 million shs$245.77 million07/16/2025$1.13$1.12-0.88%$1.16$1.102.20 million shs$221.98 million07/15/2025$1.18$1.13-4.24%$1.20$1.121.79 million shs$223.97 million07/14/2025$1.19$1.18-0.84%$1.21$1.181.42 million shs$233.88 million07/11/2025$1.24$1.19-4.03%$1.24$1.172.09 million shs$235.86 million07/10/2025$1.23$1.24+0.81%$1.25$1.202.90 million shs$245.77 million07/09/2025$1.17$1.23+5.13%$1.26$1.175.01 million shs$243.79 million07/08/2025$1.11$1.17+5.41%$1.23$1.114.64 million shs$231.89 million07/07/2025$1.17$1.11-5.21%$1.18$1.102.92 million shs$220.00 million07/04/2025$1.17$1.17$1.22$1.152.32 million shs$232.09 million07/03/2025$1.15$1.17+1.83%$1.22$1.152.32 million shs$232.09 million07/02/2025$1.00$1.15+15.00%$1.18$1.005.74 million shs$227.93 million07/01/2025$0.98$1.00+1.58%$1.04$0.952.89 million shs$198.20 million Related Companies CureVac Stock Chart Aurinia Pharmaceuticals Stock Chart Calliditas Therapeutics AB (publ) Stock Chart Phibro Animal Health Stock Chart Praxis Precision Medicines Stock Chart Jyong Biotech Stock Chart Sana Biotechnology Stock Chart Dyne Therapeutics Stock Chart Amphastar Pharmaceuticals Stock Chart Avadel Pharmaceuticals Stock Chart Receive ESPR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Esperion Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ESPR) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Esperion Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Esperion Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
